Inactive Instrument
Telik, Inc. Share Price Nasdaq
Stocks
US87959M1099
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 20/03/20 | MabVax Therapeutics Holdings, Inc. Went Out of Business | CI |
| 05/03/20 | Second Amended Liquidation Plan & Disclosure Statment Approved for MabVax Therapeutics Holdings, Inc. | CI |
| Market Cap | 1.11M 987K 921K 839K 1.58M 107M 1.6M 11.15M 4.32M 54.58M 4.17M 4.08M 175M | P/E 2016 |
-0.93x | P/E 2017 | -0.25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.59M 3.19M 2.98M 2.71M 5.12M 345M 5.17M 36.05M 13.97M 177M 13.49M 13.19M 567M | EV / Sales 2016 |
147x | EV / Sales 2017 | - |
| Free-Float |
92.02% | Yield 2016 * |
-
| Yield 2017 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
John Hansen
CEO | Chief Executive Officer | 74 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.23% | -0.59% | +52.63% | +128.54% | 43.39B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.96% | +138.26% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 148K 132K 123K 112K 211K 14.23M 213K 1.49M 576K 7.28M 556K 544K 23.35M | - |
| Net income | -17.66M -15.69M -14.65M -13.35M -25.18M -1.7B -25.41M -177M -68.68M -868M -66.31M -64.87M -2.79B | -19.02M -16.9M -15.77M -14.38M -27.11M -1.83B -27.37M -191M -73.97M -935M -71.41M -69.86M -3B |
| Net Debt | 470K 418K 390K 355K 670K 45.19M 676K 4.72M 1.83M 23.1M 1.77M 1.73M 74.15M | 2.48M 2.2M 2.06M 1.88M 3.54M 239M 3.57M 24.9M 9.65M 122M 9.32M 9.11M 391M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
